Proceedings of the Standing Senate Committee on
Social Affairs, Science and Technology
Issue 16 - Minutes of Proceedings - June 6, 2014
OTTAWA, Friday, June 6, 2014
(35)
[English]
The Standing Senate Committee on Social Affairs, Science and Technology met this day at 8:03 a.m., in room 256-S, Centre Block, the chair, the Honourable Kelvin Kenneth Ogilvie, presiding.
Members of the committee present: The Honourable Senators Chaput, Cordy, Eggleton, P.C., Nancy Ruth, Ogilvie, Seidman, Seth and Stewart Olsen (8).
In attendance: Sonya Norris, Analyst, Parliamentary Information and Research Service.
Also in attendance: The official reporters of the Senate.
Pursuant to the order of reference adopted by the Senate on Tuesday, November 19, 2013, the committee continued its study on prescription pharmaceuticals in Canada. (For complete text of the order of reference, see proceedings of the committee, Issue No. 3.)
WITNESSES:
Canadian Institute for Health Information:
Michael Gaucher, Director, Pharmaceuticals and Health Workforce Information Services.
Canada Health Infoway:
Jennifer Zelmer, Senior Vice-President, Clinical Adoption and Innovation.
Canadian Agency for Drugs and Technologies in Health:
Brian O'Rourke, President and Chief Executive Officer.
Canadian Pharmacists Association:
Perry Eisenschmid, Chief Executive Officer.
HealthCareCAN (formerly ACAHO-CHA):
Tina Saryeddine, Assistant Vice-President, Research and Policy Analysis.
Institute for Clinical Evaluative Sciences:
Dr. David Juurlink, Head, Division of Clinical Pharmacology and Toxicology, Sunnybrook Health Sciences Centre.
Psychiatric Medication Awareness Group:
Janet Currie, Representative.
Canadian Organization for Rare Disorders:
Maureen Smith, Secretary.
Canadian Institutes of Health Research:
Dr. Robert Peterson, Executive Director, Drug Safety and Effectiveness Network.
Institutional Review Board Services:
Jack Corman, President.
Rx&D:
Jared Rhines, Vice-president, Scientific and Strategic Affairs.
As individuals:
Ronald Heslegrave, Executive Director, William Osler Health System.
Amir Attaran, Canadian Research Chair, Population Health and Global Development Policy, University of Ottawa.
Mary Wiktorowicz, Chair and Associate Professor, School of Health Policy & Management, Faculty of Health, York University.
Matthew Herder, Assistant Professor, Health Law Institute, Faculties of Medicine and Law, Dalhousie University.
Canadian Generic Pharmaceutical Association:
Dr. Colin D'Cunha, Director, Global Medical Affairs, Apotex Inc..
The chair made a statement.
Mr. Gaucher, Ms. Zelmer, Mr. O'Rourke, Mr. Eisenschmid, Ms. Saryeddine, Dr. Juurlink, Ms. Currie, Ms. Smith, Dr. Peterson, Mr. Corman, Mr. Rhines, Mr. Heslegrave, Mr. Attaran, Ms. Wiktorowicz, Mr. Herder and Dr. D'Cunha each participated in a roundtable discussion.
At 10:04 a.m., the committee suspended.
At 10:18 a.m., the committee resumed.
The roundtable discussion continued.
At 12:01 p.m., the committee adjourned to the call of the chair.
ATTEST:
Jessica Richardson
Clerk of the Committee